[1]
S. A. Sabry, M. J. Ibrahem, and M. A. Jabarah, “Relationship of the quality of life in capecitabine-treated colorectal cancer patients to sociodemographic characteristics and drug-related adverse effects”, JFacMedBagdad, vol. 64, no. 3, pp. 175–182, Oct. 2022, doi: 10.32007/jfacmedbagdad.6431970.